Metaplastic breast carcinoma
MONDO:0006043A group of invasive breast carcinomas characterized by the presence of an adenocarcinomatous component which is admixed with a dominant component that is composed of squamous cells, spindle cells, or mesenchymal cells.
Also known as: metaplastic breast carcinoma, metaplastic carcinoma of breast, metaplastic carcinoma of the breast, breast metaplastic carcinoma, metaplastic breast cancer
2800 clinical trials for this condition and its sub-types, 4 tagged with Metaplastic breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Metaplastic breast carcinoma
-
Squamous cell breast carcinoma 0 trials
4 sub-types
-
New cocktail targets rare breast cancer that defies standard treatment
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—alpelisib, L-NMMA, and nab-paclitaxel—in people with a rare, aggressive form of breast cancer called metaplastic breast cancer (MpBC) that has spread or is locally advanced. The study aims to find the best dose and see if…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC